Related Experiment Video
Updated: Mar 6, 2026

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Effects of Disease Activity and Inflammatory Response on Hypercoagulability in Patients with Systemic Lupus
Yan Liang1, Rui-Xue Leng1, Hai-Feng Pan1
1Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China.
Background And Aims:
The aim of the study was to (1) investigate the possible relationships of clinical manifestations and laboratory abnormalities with hypercoagulability in systemic lupus erythematosus (SLE) patients; (2) analyze the interaction effect between SLE disease activity and erythrocyte sedimentation rate (ESR) as well as between C3 and ESR on hypercoagulability.
Methods:
The medical records of 1677 SLE patients were collected. Data on demographic characteristics, clinical manifestations, laboratory abnormalities and immunosuppressive agents use were obtained by medical record review. Coagulation score was calculated based on D-dimer and fibrinogen.
Results:
Coagulation score was associated with the presence of lupus nephritis (β-coefficient [β]: 0.046; 95% confidence interval [CI]: 0.021-0.071; p <0.001), pleuritis (β: 0.113; 95% CI: 0.074-0.151; p <0.001), pericarditis (β: 0.075; 95% CI: 0.031-0.119; p = 0.001), fever (≥38°C) (β: 0.119; 95% CI: 0.083-0.155; p <0.001), active disease (β: 0.070; 95% CI: 0.044-0.096; p <0.001) and increased ESR (β: 0.199; 95% CI: 0.171-0.226; p <0.001) in multivariate linear regression models. A significant effect on coagulation score by the interaction between SLE disease activity and ESR was found (p <0.001). In contrast, there was no significant interaction effect between C3 and ESR (p = 0.248).
Conclusions:
Lupus nephritis, pleuritis, pericarditis, fever (≥38°C), active disease and increased ESR were associated with hypercoagulability in SLE. There was a significant interaction between active disease and increased ESR for hypercoagulability in SLE.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

